asparagine

Asparagine is one of the 20 standard amino acids, classified as non-essential and polar/uncharged due to its amide side chain. It is synthesized from aspartate by asparagine synthetase, using glutamine as the nitrogen donor (glutamine-dependent amidotransferase reaction), producing glutamate as a byproduct along with AMP and pyrophosphate from ATP hydrolysis. This reaction is important in nitrogen shuttling and amino acid metabolism.

Clinically, asparagine is highly relevant in oncology: leukemic lymphoblasts (particularly in acute lymphoblastic leukemia) often lack sufficient asparagine synthetase, making them dependent on exogenous asparagine for protein synthesis and survival. This vulnerability is exploited therapeutically with L-asparaginase, an enzyme that hydrolyzes circulating asparagine into aspartate and ammonia, depleting the amino acid pool available to leukemic cells while sparing normal cells (which can synthesize their own asparagine). Side effects of asparaginase therapy include pancreatitis, hepatotoxicity, coagulopathy (due to decreased synthesis of clotting factors and antithrombin III by the liver), and hypersensitivity reactions (since it's a bacterial-derived enzyme, often from E. coli or Erwinia species).

Asparagine also plays a role in glycoprotein synthesis, as it is the amino acid residue to which N-linked glycosylation occurs (via the asparagine side chain nitrogen, in the sequence Asn-X-Ser/Thr), a critical post-translational modification occurring in the rough endoplasmic reticulum.

Metabolically, asparagine can be converted back to aspartate via asparaginase, linking it to the urea cycle and citric acid cycle (aspartate feeds into oxaloacetate).